Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Reksa Dana Premier ETF Indonesia Financial (XIIF) Price & Performance

Cipta Sarana Medika Tbk.Trade
Reksa Dana Premier ETF Indonesia FinancialTrade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Reksa Dana Premier ETF Indonesia Financial — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Reksa Dana Premier ETF Indonesia Financial trades at Rp414 (market cap 24.64B, 1.1K 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 6.6× Reksa Dana Premier ETF Indonesia Financial's market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 1.1K). Which is the better fit depends on your goals.

DKHHXIIF
Market Cap
163.22B24.64B
Volume
3.92M1.1K
Lot
39.16K11
Turnover
249.6M455.4K
Average Price
63.74414
Value
249.6M455.4K
Indicative Equilibrium Price
64
Indicative Equilibrium Volume
77

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Reksa Dana Premier ETF Indonesia Financial

Read more on XIIF